HomeNews & TopicsInfection ControlResearch reveals the fraction of asymptomatic hospital staff exposed to, infected with...

Research reveals the fraction of asymptomatic hospital staff exposed to, infected with SARS-Cov-2

Published on

A study from UHN, Canada’s largest research hospital, reveals the percentage of symptomatic and asymptomatic healthcare workers infected with the novel coronavirus.

“A key question that we wanted to answer was ‘how many asymptomatic healthcare workers are unknowingly infectious or have been exposed to the virus,’” says Dr. Deepali Kumar, senior author and a clinician investigator at the Toronto General Hospital Research Institute (TGHRI).

To answer this question, two tests were used: swab tests, to see if the virus was present and able to spread; and blood antibody tests, to see if past exposure to the virus had occurred.

The results revealed that, of symptom-free staff, around 0.5 per cent had positive swab tests. This means that around one out of every 200 staff were potentially infectious. When staff had symptoms, that number jumped to 3.4 per cent, or around seven out of every 200 individuals.

Using blood antibody tests, the research team found that between 1.4 per cent to 3.4 per cent of symptom-free staff tested positive, depending on which antibody test was used.

“This means that somewhere between three and seven staff out of every 200 had been infected with the virus without ever reporting symptoms,” says Dr. Victor Ferreira, the first author of the study and a scientific associate at TGHRI, where he works with Senior Scientist and co-author Dr. Atul Humar.

Symptoms that were considered were fever, headache, new or worsening cough, shortness of breath, sore throat, runny nose, pink eye, diarrhea, loss of sense of smell or muscle aches.

“Our findings reaffirm the importance of remaining vigilant in the screening of health care and other front line workers regardless of whether they experience COVID-19-like symptoms,” says Dr. Ferreira.

These results come from the first phase of the study called Research Platform to Screen and Protect Healthcare Workers study—or RESPECT for short, which enrolled front-line health care workers at UHN between March and June 2020. Given the success of the first phase, RESPECT 2.0 has since been initiated and expanded to include broader clinical personnel, research personnel and other workers, such as those in the food industry.

 

“This observational study has important implications for infection control, as well as staff and patient safety. And it could not have been possible without the multidisciplinary team of physicians, researchers, nurses and other allied health professionals that contributed. Thank you to everyone at TeamUHN that made this possible,” says Dr. Brad Wouters, UHN’s EVP of Science and Research.

The study was funded by the Mount Sinai Hospital and University Health Network Academic Medical Organization, the Ontario Institute for Cancer Research, the Government of Ontario, and the Toronto General & Western Hospital Foundation. T Pugh is a Tier 2 Canada Research Chair (CRC); M Cybulsky and B Wouters are Tier 1 CRCs. 

 

 

 

Latest articles

Breaking Barriers with Mobile Care

In Canada, marginalized populations face many barriers to accessing the health care they need,...

Advancing women’s health research and care

Historically, women have faced barriers in the diagnosis, treatment and care of many health...

It is time the feds make the long-awaited diabetes device fund a reality

It has been almost a year since the federal government announced that it would...

What 20 years of competency-based medical education has taught us

When the first conversations around Competency-Based Medical Education (CBME) took root in Canada in...

More like this

Using AI to improve hand hygiene and patient safety

The Ottawa Hospital (TOH) is the first in Canada to implement the Artificially Intelligent...

New study examines social influence on vaccines

According to a recent study by John D. Dimoff, Ph.D., Assistant Professor of Graduate...

MIMOSA Pro device to treat diabetic foot ulcers, prevent limb amputation

St. Michael’s Hospital has received funding for a device that helps clinicians better treat...

V-161: A breakthrough in the fight against antibiotic-resistant VRE infections

V-161 targets a crucial enzyme in VRE, offering promise in combating antibiotic-resistant infections in...

Battling Bird Flu: Critical research to protect BC from Avian Influenza

Genome BC is funding a set of research projects to address the risk associated...

COVID-19, five years later

Five years after the start of the pandemic, experts from the MUHC, the Montreal...